Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Zenith® Fenestrated+ Clinical Study

NCT: NCT04875429 · RECRUITING

NCT IDNCT04875429
StatusRECRUITING
Start Date2023-12-08
Completion2031-11
SponsorCook Research Incorporated (INDUSTRY)
First posted
Last updated

Brief Summary

The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries. Up to 60 additional subjects may be enrolled in Continued Access phase of the study

Frequently Asked Questions

What is Zenith® Fenestrated+ Clinical Study?

Zenith® Fenestrated+ Clinical Study is a clinical trial registered under NCT04875429. Current status: RECRUITING.

What is the status of NCT04875429?

The current status of NCT04875429 (Zenith® Fenestrated+ Clinical Study) is: RECRUITING.

When did Zenith® Fenestrated+ Clinical Study start?

Zenith® Fenestrated+ Clinical Study started on 2023-12-08.

Related Devices

PMA P020018SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTCook, Inc. PMA P060002System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentBard Peripheral Vascular PMA P070016SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTWilliam Cook Europe Aps PMA P110032SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTLombard Medical Limited PMA P110038SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTBolton Medical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑